HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon’s Stahl speaks out

This article was originally published in The Rose Sheet

Executive Summary

Improving business execution and developing consumer- and retail partner-based growth strategies are among top priorities for the company for "foreseeable future," CEO Jack Stahl says May 9, offering analysts insight into his plans to improve the faltering business. Increased "marketing pressure" is being inplemented now as one element. "I think we're going to have a lot to tap into as Revlon re-establishes its core brand positioning and really begins to reclaim its heritage as a power brand," Stahl states. Company will further unveil strategies for growth during an analyst conference tentatively scheduled for Aug. 2, exec adds. Stahl succeeded Jeffrey Nugent as president in February (1"The Rose Sheet" Feb. 25, 2002, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel